Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Effects of glycosaminoglycans on the glomerular changes induced by adriamycin (1995)

  • Authors:
  • USP affiliated authors: COSTA, ROBERTO SILVA - FMRP ; TEREZILA MACHADO COIMBRA - FMRP
  • USP Schools: FMRP; FMRP
  • DOI: 10.1007/bf02576808
  • Subjects: ENZIMAS
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    DOI or search this record in
    Informações sobre o DOI: 10.1007/bf02576808 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: Research in Experimental Medicine

    ISSN: 0300-9130

    Citescore - 2017: 0

    SJR - 2017: 0

    SNIP - 2017: 0


  • How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      PIERONI, F; COSTA, R. S.; COIMBRA, Terezila Machado. Effects of glycosaminoglycans on the glomerular changes induced by adriamycin. Research in Experimental Medicine, Berlin, v. 195, n. 6 , p. 373-9, 1995. DOI: 10.1007/bf02576808.
    • APA

      Pieroni, F., Costa, R. S., & Coimbra, T. M. (1995). Effects of glycosaminoglycans on the glomerular changes induced by adriamycin. Research in Experimental Medicine, 195( 6 ), 373-9. doi:10.1007/bf02576808
    • NLM

      Pieroni F, Costa RS, Coimbra TM. Effects of glycosaminoglycans on the glomerular changes induced by adriamycin. Research in Experimental Medicine. 1995 ;195( 6 ): 373-9.
    • Vancouver

      Pieroni F, Costa RS, Coimbra TM. Effects of glycosaminoglycans on the glomerular changes induced by adriamycin. Research in Experimental Medicine. 1995 ;195( 6 ): 373-9.

    Referências citadas na obra
    Bertani T, Poggi A, Pozzoni R, DeLaini F, Sacchi G, Thoua Y, Mecca G, Remuzzi G, Donati MB (1982) Adriamycin-induced nephrotic syndrome in rats. Lab Invest 46:16–23
    Weening JJ, Rennke HG (1983) Glomerular permeability and polianion in adriamycin nephrosis in the rat. Lab Invest 24:152–159
    Bertolatus JA, Hunsiker LG (1985) Glomerular sieving of anionic and neutral bovine albumins in proteinuric rats. Kidney Int 28:467–476
    Bertani T, Cutillo F, Zoja C, Brogginne M, Remuzzi G (1986) Tubulo-interstitial lesions mediate renal damage in adriamycin glomerulopathy. Kidney Int 30:488–496
    Bertani T, Rocchi G, Sacchi G, Mecca G, Remuzzi G (1986) Adriamycin-induced glomerulosclerosis in the rat. Am J Kidney Dis 7:12–19
    Okuda S, Oh Y, Tsuruda H, Onoyama K, Fujimi S, Fujishima M (1986) Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease. Kidney Int 29:502–510
    Gambaro G, Carvazzana AO, Luzi P, Piccoli A, Borsatti A, Crepaldi G, Marchi E, Venturini AP, Baggio B (1992) Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats. Kidney Int 42:285–291
    Gambaro G, Venturini AP, Noonan DM, Fries W, Garbisa GS, Milanesi C, Pesarini A, Borsatti A, Marchi E, Baggio B (1994) Treatment with glycosaminoglycan formulation ameliorates experimental diabetic nephropathy. Kidney Int 46:797–806
    Diamond JR, Karnovsky MJ (1986) Nonanticoagulant protective effect of heparin in chronic aminonucleoside nephrosis. Renal Physiol Biochem 9:366–374
    Purkerson ML, Tolelfsen DM, Klahr S (1988) N-Desulfated-acetylated heparin ameliorates the progression of renal disease in rats with subtotal renal ablation. J Clin Invest 81:69–74
    Ichikawa I, Yoshida Y, Fogo A, Purkerson ML, Klahr S (1988) Effect of heparin on the glomerular structure and function of remnant nephrons. Kidney Int 34:638–644
    Laurell CB (1972) Electroimmunoassay. Scand J Clin Lab Invest 124 [Suppl 23]:21–23
    Coimbra TM, Furtado MR, Lachat JJ, Carvalho IF (1983) Effects of administration of cationic and native homologous albumin on the kidney. Nephron 33:208–215
    Hardwicke J (1965) Estimation of renal permeability to protein on Sephadex G 200. Clin Chim Acta 12:89–96
    Granath KA, Kvist BE (1967) Molecular weight distribution analysis by gel chromatography on Sephadex. J Chromatogr 28:69–81
    Laemmli UK (1970) Cleavage of structural proteins during the assembly of head bacteriophage T4. Nature 227:680–685
    Hartree EF (1972) Determination of protein. A modification of Lowry method that gives a linear photometric response. Anal Biochem 48:422–427
    Noël L-H, Zanetti M, Droz D, Barbanel B (1979) Long-term prognosis of idiopathic membranous glomerulonephritis. Am J Med 66:82–90
    Hays WL (1973) Statistics for social sciences. Holt, Rinehart and Winston. New York, pp 605–607
    Klein DJ, Oegema TR, Brown DM (1989) Release of glomerular heparan35SO4 proteoglycan by heparin from glomeruli of streptozotocin-induced diabetic rats. Diabetes 38:130–139
    Nader HB, Buonassisi V, Colburn P, Dietrich CP (1989) Heparin stimulates the synthesis and modifies the sulfation pattern of heparan sulfate proteglycans from endothelial cells. J Cell Physiol 140:305–310
    Olson JL (1984) Role of heparin as protective agent following reduction of renal mass. Kidney Int 25:376–382
    Floege J, Eng E, Young BA, Couser WG, Johnson RJ (1993) Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis. Kidney Int 43:369–380
    Castellot JJ, Hoover RL, Harper PA, Karnowsky MJ (1985) Heparin and glomerular epithelial cell-secreted heparin-like species inhibit mesangial cell proliferation. Am J Pathol 120:427–435
    Person JM, Lovett DH, Raugi GJ (1988) Modulation of mesangial cell migration by extracellular matrix components. Inhibition by heparin-like glycosaminoglycans. Am J Pathol 133:609–614
    Groggel GH, Marinides GN, Hovingh P, Hammond E, Linker A (1990) Inhibition of rat mesangial cell growth by heparan sulfate. Am J Physiol 258:F259-F265
    Johnson RJ, Floege J, Couser WG, Alpers CE (1992) Role of platelet-derived growth factor in glomerular disease. J Am Soc Nephrol 4:119–128
    Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E (1993) Glomerulosclerosis induced by in vivo transfection of transforming growth factor B or platelet-derived growth factor gene into the kidney. J Clin Invest 92:2597–2601
    Fogo A (1994) Internephron heterogenity of growth factors and sclerosis. Kidney Int [Suppl]45:S24-S26